Literature DB >> 27207870

Multiple sclerosis disease-modifying therapy and pregnancy.

Aaron E Miller1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27207870     DOI: 10.1177/1352458516642316

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database.

Authors:  Magnhild Sandberg-Wollheim; Orit Neudorfer; Augusto Grinspan; Bianca Weinstock-Guttman; Judith Haas; Guillermo Izquierdo; Claire Riley; Amy Perrin Ross; Peleg Baruch; Talya Drillman; Patricia K Coyle
Journal:  Int J MS Care       Date:  2018 Jan-Feb

Review 2.  Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

Authors:  Raed Alroughani; Ayse Altintas; Mohammed Al Jumah; Mohammadali Sahraian; Issa Alsharoqi; Abdurahman AlTahan; Abdulkader Daif; Maurice Dahdaleh; Dirk Deleu; Oscar Fernandez; Nikolaos Grigoriadis; Jihad Inshasi; Rana Karabudak; Karim Taha; Natalia Totolyan; Bassem I Yamout; Magd Zakaria; Saeed Bohlega
Journal:  Mult Scler Int       Date:  2016-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.